Q4 2024 Bausch + Lomb Corp Earnings Call Transcript
Key Points
- Bausch & Lomb Corp (BLCO) achieved its fifth consecutive quarter of double-digit constant currency revenue growth, contributing to a 17% growth for the year.
- The company has successfully introduced new products across various geographies and optimized its manufacturing processes, including the deployment of AI.
- BLCO's R&D organization has been overhauled, leading to a promising pipeline filled with innovative products, such as a first-of-its-kind Biomimetic contact lens.
- The company's dry eye portfolio is nearing $1 billion in annual revenue, with significant contributions from products like Miebo and Xiidra.
- BLCO's contact lens segment reported strong growth, with daily SiHy lenses achieving over 70% revenue growth for the year.
- The company faces currency headwinds, which impacted revenue by $69 million and adjusted EBITDA by $11 million for the full year.
- BLCO anticipates a $25 million impact from the Inflation Reduction Act in 2025, affecting adjusted gross margin.
- The company is investing heavily in R&D and direct-to-consumer campaigns, which may impact short-term profitability.
- BLCO's guidance for 2025 reflects a slowdown in revenue growth to 5.5% to 7.5%, compared to the previous year's 17% growth.
- The company is absorbing a $20 million impact related to the recent acquisition of Elios, which may affect short-term financial performance.
Greetings. Welcome to the Bausch and Lomb Fourth quarter 2024 earnings call. (Operator instructions)
I will now turn the conference over to your host, George Gadkowski , Vice President, Investor Relations. You may begin.
Thank you. Good morning, everyone, and welcome to our fourth quarter of 2024 financial results conference call. Participating on today's call our Chairman and Chief Executive Officer Mr. Brent Saunders and Chief Financial Officer, Mr. Sam Eldessouky.
In addition to this live webcast, a copy of today's live presentation and a replay of this conference call will be available on our website under the investor relations section. Before we begin, I would like to remind you that our presentation today contains forward-looking information. We would ask that you take a moment to read the forward-looking legend at the beginning of our presentation as it contains important information.
This presentation contains non-GAAP financial measures and ratios. For more
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
